Epstein Secrets

From: Lesley Groff <1 To: David Carter c4 Subject: Re: Investment Opportunities Date: Fri, 06 Mar 2015 15:42:18 +0000 terrific. I will forward on...thanks On Mar 6, 2015, at 10:28 AM,

opment. They just need about $1.5M to get into the clinic, and generate the data for product approval. With the clinical data in hand the balance of Prediction's financing should be relatively easy. EFTA00351823 OvationBio: OvationBio is super early. It will be a challenge to find investors, sensitive to

Opportunities-David Carter Date: Fri, 06 Mar 2015 15:42:07 +0000 Attachments: DaCart_Presentation Mar 2 2015.pptx Begin forwarded message: From: "David Carter" < Subject: FW: Investment Opportunities Date: March 6, 2015 at 10:28:30 AM EST To: From: David Carter [madto: Sent: Thursday, March 05, 2015 11

opment. They just need about $1.5M to get into the clinic, and generate the data for product approval. With the clinical data in hand the balance of Prediction's financing should be relatively easy. OvationBio: OvationBio is super early. It will be a challenge to find investors, sensitive to risk and retur

From: "David Carter" To:' <Ma> Subject: FW: Investment Opportunities Date: Fri, 06 Mar 2015 15:28:30 +0000 Attachments: DaCart_Presentation_Mar_2_2015.pptx From: D

pment. They just need about $1.5M to get into the clinic, and generate the data for product approval. With the clinical data in hand the balance of Prediction's financing should be relatively easy. OvationBio: OvationBio is super early. It will be a challenge to find investors, sensitive to risk and retur